<DOC>
	<DOCNO>NCT01256450</DOCNO>
	<brief_summary>The purpose study determine whether buprenorphine hydrochloride ( HCl ) buccal film effective safe treatment chronic low back pain ( CLBP ) .</brief_summary>
	<brief_title>Efficacy Safety Study Buprenorphine HCl Buccal Film Subjects With Low Back Pain</brief_title>
	<detailed_description>This enriched enrollment , randomize withdrawal study open label , dose-titration period follow randomized , double-blind , placebo-controlled treatment period 12 week . During double-blind treatment period , study evaluate effectiveness buprenorphine HCl buccal film versus placebo buccal film treat CLBP subject . Buprenorphine HCl buccal film oral transmucosal form opioid analgesic , buprenorphine hydrochloride , intend application buccal mucosa . Buprenorphine synthetic opioid classify partial µ-receptor agonist Schedule III control substance United States .</detailed_description>
	<mesh_term>Back Pain</mesh_term>
	<mesh_term>Low Back Pain</mesh_term>
	<mesh_term>Buprenorphine</mesh_term>
	<criteria>Male nonpregnant nonnursing female age 18 old History moderate severe chronic low back pain ≥3 month pain intensity ≥5 [ 11 point numerical rating scale ] report openlabel titration period Day 0/1 visit follow washout period ( opioids , nonsteroidal antiinflammatory drug [ NSAIDs ] , muscle relaxant ) approximately 12 24 hour Currently take ≤60 mg oral morphine/day equianalgesic dose another opioid ( include opioid naïve ) 1 week longer Stable health , determine Investigator , basis medical history , physical examination , screen laboratory result comply study procedure Female subject childbearing potential must use recognize effective method birth control Written inform consent obtain Screening , prior procedure perform Reflex sympathetic dystrophy causalgia ( complex regional pain syndrome ) , acute spinal cord compression , cauda equina compression , acute nerve root compression , meningitis , discitis Surgical procedure back pain within 2 month prior screen nerve/plexus block within 4 week screen Hypokalemia clinically unstable cardiac disease , include : unstable atrial fibrillation , symptomatic bradycardia , unstable congestive heart failure , active myocardial ischemia Corrected QT ( QTc ) interval &gt; 450 millisecond 12lead electrocardiogram ( ECG ) History long QT syndrome , immediate family member condition Diagnosis moderate severe hepatic impairment . History severe emesis opioids Clinically significant sleep apnea</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>buccal soluble film</keyword>
	<keyword>enrich enrollment</keyword>
	<keyword>randomize withdrawal</keyword>
</DOC>